ArticleMaterials today. Bio2026
4D morphogenetic tissue engineering via gradient-crosslinked microporous hydrogel scaffolds.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Smart Hydrogel Design to 4D-Printed Scaffolds: Emerging Paradigms in Precision Drug Delivery and Regenerative Wound Therapy.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shape-morphing hydrogels offer great promise for 4D tissue engineering by enabling dynamic scaffolds that recapitulate morphogenetic transformations. However, their densely crosslinked networks often restrict mass transport, nutrient diffusion, and extracellular matrix remodeling, limiting tissue development. Here, we present a strategy to engineer microporous gradient hydrogels with programmable shape morphing for 4D tissue engineering. Gradient network densities were generated through light-attenuation-mediated photocrosslinking, while interconnected micropores were introduced using sacrificial gelatin microspheres (GMSs). The resulting internal stress mismatch induced differential swelling, enabling controlled shape transformations. By tuning GMS content, photocrosslinking time, and construct geometry, precise control over microporosity, mechanical stiffness, swelling, and deformation behavior was achieved. The constructs supported high cell viability and maintained deformability after cell encapsulation. Complex 3D shapes with varied curvature profiles were readily realized by modulating gradient direction and range. As a proof of concept, mesenchymal stem cell (MSC)-laden constructs were osteogenically differentiated for four weeks to form bone-like tissues. The gradient constructs retained stable curved configurations, and GMS incorporation markedly enhanced alkaline phosphatase (ALP) activity and calcium deposition compared to nonporous controls. This study establishes a versatile and tunable platform for creating microporous gradient hydrogels with spatiotemporal morphing capabilities, offering a new route for developing dynamic, cell-instructive scaffolds in 4D tissue engineering.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.